Current and developing treatments for viruses and bacteria in asthma and COPD

S. L. Johnston (London, United Kingdom)

Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation

Session: PG9 - The role of infection in airway inflammation and exacerbation
Session type: Postgraduate Course
Number: 30

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. L. Johnston (London, United Kingdom). Current and developing treatments for viruses and bacteria in asthma and COPD. Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010
Role of viral pathogens in infectious exacerbations of bronchial asthma in adults Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019
The investigation of infectious agents and their antibiotic sensitivities in COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
Viral and bacterial infections in exacerbations of asthma and COPD Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation Year: 2004
The role of viral and bacterial infections on the development and exacerbations of asthma Source: Eur Respir Mon 2012; 56: 115-127 Year: 2012
The role of viral infections in asthma and asthma exacerbations Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma Year: 2010
COPD: antibiotic strategy in infectious exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001
Role of viruses and atypical agents in COPD acute exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013
Effect of different asthma treatments on risk of cold-related exacerbations Source: Eur Respir J 2011; 38: 584-593 Year: 2011
The economic burden of respiratory diseases: COPD and asthma Source: Eur Respir Monogr 2014; 65: 116-124 Year: 2014
How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014
Spectrum of viral pathogens in adults patients with infectious exacerbations of bronchial asthma Source: Annual Congress 2013 –Viral infections Year: 2013
Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020